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ABSTRACT – More HIV-positive patients are living longer and
presenting to non-infection specialties with non-HIV-related
issues (eg diabetes, heart disease). National recommendations
advise routinely offering HIV testing to all new registrants to pri-
mary care and all general medical admissions where community
prevalence exceeds 2:1000.1,2 It is, therefore, imperative that all
physicians are educated and competent in HIV infection, coun-
selling and testing. This study aimed to establish regional med-
ical registrars’ opinions on teaching provision, and confidence in,
HIV medicine. The results indicated a lack of confidence in HIV
medicine and, in those without postgraduate rotations in HIV
medicine or infectious diseases, a perception that HIV and
infection-related teaching provision is inadequate.
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Methods
A cross-sectional, descriptive study evaluating 123 general med-
ical registrars’ opinions through a questionnaire distributed at a
North West deanery-wide education day was performed. The
primary outcome measure was confidence in HIV-related clin-
ical issues (counselling, needlestick advice, opportunistic infec-
tions (OIs) and highly active antiretroviral therapy (HAART))
and opinions on HIV and infection teaching (microbiology,
tropical medicine, virology, infectious diseases, herein termed
‘infection-related’ teaching) received as under- and postgradu-
ates. Scoring was from 1–5 (1 being poor, 3 adequate, 5 excel-
lent). Secondary outcome measures included frequency of HIV
counselling and testing.
Results
Of 244 registrars within the local deanery, 123 (50%) attended the
education day and 102 (83%) completed the questionnaire. Of
these, 17 (17%) had previous postgraduate placements in HIV,
genitourinary medicine (GUM) or infectious diseases (ID); the
median duration being four months (range 2–23 months).
Fifty-six (55%) had performed an HIV test on a patient
between one and five times over the past six months, but 23
(22%) had not tested a patient for HIV for over six months (data
not shown).
Registrars (n102) on average felt most competent dealing
with needlestick injuries (mean score 3.6/5) and pre-test HIV
counselling (3.8/5), adequately competent in OI knowledge
(3.0/5) but not competent in post-test counselling (2.7/5) or
knowledge of HAART (2.3/5) (Fig 1). There were no signifi-
cant differences in these outcomes with place of qualification
or previous HIV/GUM/ID experience (data not shown).
Composite undergraduate infection-related teaching (mean
average of tropical medicine, HIV, ID, microbiology, and
virology teaching combined) was significantly poorer in doc-
tors qualifying from the North West region when compared
with those qualifying from other UK regions or abroad
(p0.0001; Table 1).
Though postgraduate teaching was uniformly scored as inad-
equate, there was geographical variation. Those qualifying in
other UK areas scored their composite postgraduate infection-
related teaching as better than those from the North West region
or those who qualified abroad (p0.012; Table 2). Overall, most
undergraduate and postgraduate infection-related teaching was
rated as less than adequate (Fig 2). Those with previous
ID/GUM/HIV exposure (n17) scored their composite post-
graduate infection teaching as significantly better than those
without (n85) (p0.0002; Table 2 and Fig 3).
Discussion
Since the advent of HAART, there has been a dramatic
improvement in the mortality, morbidity and life expectancy
of HIV-positive patients.3 Consequently, more are presenting
to non-infection healthcare professionals with issues not
directly related to HIV (eg diabetes, heart disease) and age-
related diseases.4 Recent guidelines suggest that general
medical admissions and general practitioner registrants
should routinely be offered HIV testing in an area where
community prevalence exceeds 2:1000.1,2 Therefore, general
physicians should become competent in HIV counselling
and testing, and in their knowledge of HIV-specific clinical
issues. There are no significant data in the literature investi-
gating clinicians’ perceptions of their training and compe-
tence in these issues.
This study demonstrated a distinct, perceived lack of knowl-
edge of HAART. Poor HAART prescribing practices by non-
infection specialty doctors for HIV inpatients has been previously
recognised,5 with estimated errors in up to 25% of inpatient
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HAART prescriptions.6,7 This may lead to:
• additional toxicity
• decreased compliance
• harmful drug–drug interactions
• creation of drug resistance.5,8
Trained HIV pharmacist participation and better education in
multidisciplinary teams has been shown to mitigate these
errors.9 Lack of confidence surrounding
HIV medicine appeared to be indepen-
dent of previous experience in
GUM/HIV/ID, year or place of qualifica-
tion. This may indicate that despite this
previous specialty experience and – as
shown in Fig 3 – better postgraduate
teaching, clinicians feel they de-skill
quickly when not exposed to HIV medi-
cine on a regular basis. HIV teaching ses-
sions would therefore be best provided
regularly.
These results indicate that registrars in
the Manchester region are performing
relatively few HIV tests despite British
HIV Association/National Institute for
Health and Clinical Excellence
(BHIVA/NICE) guidelines in an area
with a local HIV prevalence of
3.5–5/1000.10 This may be related to lack
of confidence or training. It is essential that testing be offered
early to avoid late presentation (at low CD4 counts), poor
response to HAART and subsequent increased mortality.11–13
Overall, general medical registrars perceive both under- and
postgraduate teaching in infection-related subjects to be poor. Only
microbiology and ID teaching were scored as adequate at an under-
graduate level; all other teaching was scored as inadequate. With a
large proportion of admissions and general practitioner consulta-
tions being infection-related (including methicillin-resistant
Staphylococcus aureus, Clostridium difficile), it is essential these sub-
jects are taught well. Of note, the 2009 UK curricula for general
internal medicine makes scarce reference to infection-related areas
with HIV being mentioned only four times in 191 pages.14
There are several drawbacks to this study. Firstly, despite an
83% response rate, numbers are small and cannot be applied
nationally. Secondly, the sample only represented half the general
medical registrars in the deanery. Thirdly, how respondents rated
quality of other specialty teaching received was not assessed, so
comparisons with infection-related teaching cannot be made.
Conclusions
Medical registrars do not feel competent in their knowledge of
HAART or post-test counselling and feel both undergraduate
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and postgraduate HIV and infection teaching has been inade-
quate. Teaching in these areas significantly improved with pre-
registrar exposure to ID/GUM/HIV.
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